Metal Non-Covered Biliary Stent Market Size, Share, Growth, And Industry Analysis, By Type (Absorbable, Non Absorbable), By Application (Hospital, Medical Center), Regional Insights and Forecast To 2035

•   
•   
  

  Request a Free sample to learn more about this report

    

METAL NON-COVERED BILIARY STENT MARKET OVERVIEW

The global Metal Non-Covered Biliary Stent Market size is valued at USD 0.33 billion in 2025 and is expected to reach USD 0.35 billion in 2026, progressing steadily to USD 0.49 billion by 2035, exhibiting a CAGR of 4.5% over the forecast period 2025-2035.In 2025, North America is projected to dominate the Metal Non-Covered Biliary Stent Market with a 45% share, driven by the rising prevalence of gastrointestinal disorders and adoption of advanced medical devices.

A metal non-covered biliary stent is a medical device used in the treatment of biliary strictures or obstructions. The biliary system consists of ducts that carry bile, a digestive fluid, from the liver to the small intestine. When these ducts become blocked or narrowed, it can lead to various complications, such as jaundice or infection. Biliary stents are designed to restore the normal flow of bile by creating a pathway through the obstruction. Unlike covered biliary stents, which are coated with a synthetic material, metal non-covered stents are made entirely of metal, typically stainless steel or nitinol. The use of metal provides several advantages. Firstly, metal stents have a higher radial force, meaning they are more resistant to compression and collapse, which helps maintain the patency of the stent. Additionally, the absence of a covering allows for better tissue ingrowth into the stent, promoting long-term stability and reducing the risk of migration.

The metal non-covered biliary stent market refers to the segment of the medical devices industry that focuses on the production and distribution of metal stents used for treating biliary disorders. These stents are designed to provide support and maintain the patency of the bile ducts, ensuring the proper flow of bile from the liver to the small intestine. Metal non-covered biliary stents are primarily used in the treatment of various biliary diseases, including biliary strictures, malignant and benign biliary obstructions, and postoperative biliary leaks.

KEY FINDINGS

COVID-19 IMPACT

Pandemic Caused Postponement or Cancellation of Elective Procedures Hampering the Market Growth

The global COVID-19 pandemic has been unprecedented and staggering, with metal non-covered biliary stent market experiencing higher-than-anticipated demand across all regions compared to pre-pandemic levels. The sudden rise in CAGR is attributable to the market's growth and demand returning to pre-pandemic levels once the pandemic is over.

The outbreak of the COVID-19 pandemic has had a significant impact on the metal non-covered biliary stent market. Firstly, the pandemic has led to disruptions in the healthcare systems globally, with resources and medical personnel being redirected towards managing COVID-19 patients. This has resulted in the postponement or cancellation of elective procedures, including those involving the placement of biliary stents. As a result, the market witnessed a decline in procedural volumes during the initial phase of the pandemic. Additionally, the economic impact of the pandemic has affected healthcare budgets, leading to reduced healthcare expenditures in some regions. This has further impacted the market growth as hospitals and healthcare facilities focused on essential medical supplies and equipment, leading to a decreased demand for non-urgent procedures such as biliary stenting.

LATEST TRENDS

Increasing Preference for Minimally Invasive Procedures to Boost the Market Development

Minimally invasive techniques, such as endoscopic retrograde cholangiopancreatography (ERCP), have gained popularity due to their advantages, including shorter hospital stays, reduced postoperative pain, and faster recovery times. Metal non-covered biliary stents are commonly placed during ERCP procedures for the treatment of biliary obstructions. The trend towards minimally invasive procedures is driving the demand for metal non-covered biliary stents as they are well-suited for such techniques.

• According to the U.S. National Library of Medicine, approximately 200,000 cases of biliary obstruction are reported annually in the United States, with metal non-covered biliary stents increasingly preferred due to their durability and long-term patency compared to plastic alternatives.

• As per the American Society for Gastrointestinal Endoscopy (ASGE), over 65% of endoscopic biliary stent placements now utilize metal non-covered stents, reflecting a shift in clinical practice over the last five years aimed at improving patient outcomes and reducing repeat procedures.

•   
•   
  

  Request a Free sample to learn more about this report

    

METAL NON-COVERED BILIARY STENT MARKET SEGMENTATION

By Type

According to type, the market can be segmented into absorbable, non-absorbable. Absorbable being the leading segment of the market by type analysis.

By Application

Based on application, the market can be divided into Hospital, Medical Center. Hospital being the leading segment of the market by application analysis.

DRIVING FACTORS

Growing Prevalence of Biliary Disorders to Drive the Market Growth

The increasing prevalence of biliary disorders, including biliary strictures, bile duct stones, and bile duct cancers, is a major driver for the metal non-covered biliary stent market. Factors such as an aging population, lifestyle changes, and the rising incidence of risk factors like obesity and diabetes contribute to the higher prevalence of biliary disorders. As the number of patients diagnosed with these conditions rises, the demand for metal non-covered biliary stents increases, as they are a crucial treatment modality for managing such disorders.

• According to the World Health Organization (WHO), biliary tract cancers account for about 15% of all primary liver malignancies worldwide, driving the demand for effective biliary stenting solutions such as metal non-covered stents to alleviate obstruction and improve patient quality of life.

• The U.S. Food and Drug Administration (FDA) reports that the average life expectancy of metal non-covered biliary stents is approximately 6 to 12 months, significantly longer than plastic stents, encouraging medical facilities to adopt them to minimize the need for frequent replacements.

Technological Advancements in Stent Design to Drive the Market Development

Advancements in stent design have significantly improved the efficacy and safety of metal non-covered biliary stents. The introduction of self-expanding stents and the development of new materials with improved biocompatibility and durability have enhanced the performance of these stents. Moreover, the integration of advanced imaging technologies, such as fluoroscopy and endoscopic ultrasound, allows for precise stent placement and better patient outcomes. These technological advancements drive the adoption of metal non-covered biliary stents and contribute to market growth.

RESTRAINING FACTORS

Risk of Stent-Related Complications to Impede the Market Growth

Although metal non-covered biliary stents offer effective treatment for biliary disorders, they are associated with potential complications, such as stent migration, stent occlusion, and tissue ingrowth. The occurrence of these complications can lead to additional interventions, increased healthcare costs, and patient discomfort. Manufacturers and healthcare professionals must focus on developing and implementing strategies to minimize these complications and improve patient outcomes.

• According to the National Institute of Health (NIH), 15-20% of metal non-covered biliary stents may lead to stent occlusion or tumor ingrowth within the first 6 months of placement, posing challenges in clinical management and restraining market growth.

• The Centers for Medicare & Medicaid Services (CMS) highlight that the cost of metal non-covered biliary stents is on average 3 to 5 times higher than plastic stents, impacting healthcare providers' purchasing decisions, especially in cost-sensitive healthcare systems.

•   
•   
  Request a Free sample to learn more about this report

    

METAL NON-COVERED BILIARY STENT MARKET REGIONAL INSIGHTS

High Prevalence of Biliary Disorders, Including Biliary Strictures, Bile Duct Stones, And Bile Duct Cancers in North America to Bolster the Market Development

The North American market for metal non-covered biliary stents holds significant potential due to several factors. Firstly, the region has a high prevalence of biliary disorders, including biliary strictures, bile duct stones, and bile duct cancers. This can be attributed to factors such as lifestyle changes, obesity rates, and an aging population. The increasing incidence of these disorders drives the demand for effective treatment options, including metal non-covered biliary stents. Additionally, North America boasts advanced healthcare infrastructure, including well-equipped hospitals and specialized healthcare centers. The availability of advanced imaging technologies and experienced healthcare professionals contributes to the adoption of metal non-covered biliary stents. The region's robust healthcare system enables efficient diagnosis, treatment, and management of biliary disorders, further fueling the market growth.

The Asia Pacific region is poised to experience substantial growth in the metal non-covered biliary stent market. This can be attributed to various factors, starting with the increasing prevalence of biliary disorders in the region. Rapid urbanization, changing lifestyles, and an aging population contribute to the rising incidence of biliary conditions such as biliary strictures and bile duct stones. As the number of patients diagnosed with these disorders increases, the demand for effective treatment options, including metal non-covered biliary stents, is expected to rise significantly. Furthermore, the Asia Pacific region has been witnessing rapid healthcare infrastructure development. Countries such as China, India, and Japan have been making significant investments in healthcare facilities, including hospitals, clinics, and specialized healthcare centers. This improved infrastructure supports the diagnosis, treatment, and management of biliary disorders, driving the demand for metal non-covered biliary stents.

KEY INDUSTRY PLAYERS

Key Players Focus on Partnerships to Gain a Competitive Advantage

Prominent market players are making collaborative efforts by partnering with other companies to stay ahead of the competition. Many companies are also investing in new product launches to expand their product portfolio. Mergers and acquisitions are also among the key strategies used by players to expand their product portfolios.

• Boston Scientific: According to the U.S. FDA database, Boston Scientific holds over 30 approved medical devices related to biliary stenting, establishing itself as a key innovator in the metal non-covered biliary stent market.

• Merit Medical: As per the U.S. FDA records, Merit Medical’s biliary stents have been involved in over 10,000 clinical procedures worldwide, underscoring their active role in advancing stent technology and expanding market share.

List of Top Metal Non-Covered Biliary Stent Companies

• Boston Scientific (U.S.)
• Taewoong Medical (South Korea)
• Merit Medical (U.S.)
• Cook Medical (U.S.)
• PNN Medical (Denmark)
• Teleflex (U.S.)
• C.R. Bard (U.S.)

REPORT COVERAGE

This research profiles a report with extensive studies that take into description the firms that exist in the market affecting the forecasting period. With detailed studies done, it also offers a comprehensive analysis by inspecting the factors like segmentation, opportunities, industrial developments, trends, growth, size, share, and restraints. This analysis is subject to alteration if the key players and probable analysis of market dynamics change.